Bisecco, Alvino http://orcid.org/0000-0002-7202-4445
Matrone, Federica
Capobianco, Marco
De Luca, Giovanna
Filippi, Massimo
Granella, Franco
Lus, Giacomo
Marfia, Girolama Alessandra
Mirabella, Massimiliano
Patti, Francesco
Trojano, Maria
Mascolo, Agnese
Copetti, Massimiliano
Tedeschi, Gioacchino
Gallo, Antonio
Malucchi, Simona
Talentacci, Maria
Tomassini, Valentina
Farina, Deborah
Moiola, Lucia
Nozzolillo, Agostino
Franceschini, Alessandro
Minetti, Matteo
Signoriello, Elisabetta
Romano, Giuseppe
Risi, Mario
d’Ambrosio, Alessandro
Landi, Doriana
Nicoletti, Carolina Gabri
Bianco, Assunta
Lucchini, Matteo
Chisari, Clara
Toscano, Simona
Paolicelli, Damiano
Iaffaldano, Pietro
Inglese, Matilde
Cellerino, Maria
Bellantonio, Paolo
Fantozzi, Roberta
Salemi, Giuseppe
Ragonese, Paolo
Danni, Maura
Coniglio, Gabriella
Ferraro, Diana
Maniscalco, Giorgia Teresa
Conte, Antonella
Cavalla, Paola
Vianello, Marika
Cargnelutti, Daniela
Gatto, Maurizia
Buonaventura, Ardito
Lugaresi, Alessandra
Amato, Maria Pia
Gazzola, Paola
Iodice, Rosa
Pesci, Ilaria
Montepietra, Sara
Pozzilli, Carlo
Ferraro, Elisabetta
Zaffaroni, Mauro
Nasuelli, Davide
,
Funding for this research was provided by:
Università degli Studi della Campania Luigi Vanvitelli
Article History
Received: 26 July 2023
Revised: 25 October 2023
Accepted: 27 October 2023
First Online: 20 November 2023
Declarations
:
: AB has received speaker honoraria and/or compensation for travel grant and consulting service from Biogen, Merck, Genzyme, Novartis, Alexion, Coloplast and Roche. F.M., A.M., and M.C. have no disclosures. M.C. received personal fees for speaking honoraria and advisory board participation by Biogen, Merck, Novartis, Sanofi, Roche. G.D.L. has served on scientific advisory boards for Merck, Biogen, Novartis, Roche, and Sanofi Genzyme and has received funding for travel and speaker honoraria from Biogen, Merck, Novartis, Sanofi Genzyme, and Roche. M.F. is an Editor-in-Chief of the Journal of Neurology, Associate Editor of Human Brain Mapping, Associate Editor of Radiology, and Associate Editor of Neurological Sciences; received compensation for consulting services and/or speaking activities from Alexion, Almirall, Bayer, Biogen, Celgene, Eli Lilly, Genzyme, Merck-Serono, Novartis, Roche, Sanofi, Takeda, and Teva Pharmaceutical Industries; and received research support from Biogen Idec, Merck-Serono, Novartis, Roche, Teva Pharmaceutical Industries, Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla, and ARiSLA (Fondazione Italiana di Ricerca per la SLA). F.G. has received research funding from Roche; fees for advisory boards and speaker honoraria from Biogen, Merck Serono, Novartis, Roche, and Sanofi Genzyme; travel funding from Biogen, Sanofi Genzyme, and BMS. G.L. received personal compensation for speaking or consultancy from Biogen, Teva, Genzyme, Merck, Novartis, Almirall, Merz, and Ipsen. G.A.M. received personal compensation for travel grant, speaking and consultancy from Alexion, Almirall, Biogen Idec, Bristol Myers Squibb, Merck-Serono, Mylan, Novartis, Roche, Sanofi-Genzyme. M.M. received consulting and/or speaking fees, research support or travel grants from Almirall, Bayer Schering, Biogen, CSL Behring, Sanofi-Genzyme, Merck, Novartis, Teva, Roche, Viatris (Mylan). F.P. received speaker honoraria or advisory board fees from Almirall, Bayer, Biogen, Celgene, Merck, Myalin, Novartis, Roche, Sanofi-Genzyme and TEVA. He received research funding from Ministero Italiano della Università e della Ricerca Scientifica, Fondazione Italiana Sclerosi Multipla, Biogen and Merck. M.T. has served on scientific advisory boards for Biogen, Novartis, Roche, and Merck; has received speaker honoraria from Biogen, Sanofi, Merck, Roche, Teva, and Novartis; and has received research grants for her Department from Biogen, Merck, Roche, and Novartis. G.T. has received compensation for consulting services and/or speaking activities from Biogen, Novartis, Merck, Genzyme, Roche, Teva; and receives research support from Biogen Idec, Merck Serono, and Fondazione Italiana Sclerosi Multipla. A.G. received personal compensation for travel grant, speaking and consultancy from Biogen, Bristol Myers Squibb, Merck-Serono, Mylan, Novartis, Roche, Sanofi-Genzyme, and Teva.
: This study was conducted using longitudinal, prospectively acquired clinical data extracted from the IMSR (ExternalRef removed). The IMSR was approved by the ethical committee (EC) of the Azienda Ospedaliero-Universitaria – Policlinico of Bari (Study REGISTRO SM001, approved on August 7, 2016) and the local EC of all participating centers.
: All patients signed informed consent allowing the use of demographical and clinical data for research purposes.
: All patients signed informed consent allowing the use of demographical and clinical data for research purposes.